|
Patent landscape, scope, and claims: |
US Patent 4,335,139: Scope, Claims, and US Patent Landscape
What does US Patent 4,335,139 cover?
US 4,335,139 is an issued US patent covering a pharmaceutical composition and related process/therapy aspects for [the specific active ingredient and drug product are not identifiable from the provided prompt alone]. The scope is determined by the exact wording of the independent claims, their dependencies, and the definitions in the specification. Without the claim text and bibliographic identifiers (title, assignee, publication family links), a complete and accurate scope and claims map cannot be produced.
What are the independent claims and how broad are they?
A complete claims analysis requires the actual claim set (claim numbers, verb forms, limitation terms, and dependency structure). That claim set is not present in the provided input. Without the claim language, any summary would be non-verifiable.
How do dependent claims narrow coverage?
A proper dependent-claim narrowing analysis requires claim text to identify:
- which elements are added (e.g., carrier type, dose form, formulation ranges)
- which limitations are structural (chemical features) vs procedural (process steps)
- which limitations define patient populations, dosing schedules, or administration routes
No claim text or specification excerpts were provided.
What is the US patent landscape around this patent?
A landscape analysis requires at minimum:
- the drug substance (INN/USAN or chemical name)
- the assignee/applicant
- the filing dates and priority dates
- the citation set (forward and backward), including related continuations, divisionals, and reissues
None of these inputs are included in the prompt, so a landscape cannot be constructed without fabricating data.
Evidence and claim-term extraction (required for scope and validity positioning)
No extractable evidence was provided in the prompt. To produce a correct analysis, the following must be sourced from the patent record and claim text:
- Claim 1 (and other independent claims): full text
- Definitions in specification: scope-defining language
- Markush groupings or optional elements: must be quoted and mapped
- Method-of-treatment vs composition claims: determines overlap with generics
- Preferred embodiments and working examples: can inform claim interpretation
No patent record content is present in the input, so this analysis cannot be completed accurately.
Key Takeaways
- A complete, accurate scope and claims analysis for US 4,335,139 cannot be produced from the provided prompt.
- A reliable US patent landscape requires drug identity, assignee, priority data, and claim text, none of which are included here.
- Any attempt to “fill in” claim scope, coverage boundaries, or landscape relationships would require sourcing facts not present in the input and would not meet an evidentiary standard.
FAQs
-
Can you map US 4,335,139’s claim scope without the claim text?
No. Scope hinges on the exact wording of independent and dependent claims.
-
Can you identify the patent’s likely drug substance and dosage form from the patent number alone?
Not in this context. The prompt does not include bibliographic details or the title.
-
Can you assess infringement risk without knowing the claim elements?
No. Element-by-element mapping requires the actual claim limitations.
-
Can you build a forward/backward US landscape without assignee and priority data?
No. Landscape construction depends on family links, citation chains, and related applications.
-
What is the minimum information needed for a full claims-and-landscape report?
The patent record’s claim set plus bibliographic identifiers and family link data.
References
[1] No source material was provided in the prompt to cite.
More… ↓
⤷ Start Trial
|
